Alon Y. Hershko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alon Y. Hershko has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
Yaakov Naparstek
Department of Medicine, Hadassah University Hospital, P.O.B. 12000, IL-91120, Jerusalem, Israel
2 shared publications
Latest Publications
- 30 April 2006
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (4) , 230-233
Autoimmunity in the era of genomics and proteomics
- 30 April 2006
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (4) , 230-233
Autoimmunity in the era of genomics and proteomics
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1051 (1) , 635-646
Removal of Pathogenic Autoantibodies by Immunoadsorption
Autoimmune diseases result from disrupted tolerance to self-antigens and subsequent damage to tissues and organs. In several diseases, specific autoantibodies have been either proved or suspected to play a role in this process. Consequently, several strategies have been devised in an attempt to discard the destructive immunoglobulins. Currently, both nonselective and epitope-specific methods are applied in several diseases. In this review, we provide a summary of the available data on elimination of pathogenic autoantibodies and discuss the advantages and pitfalls of the different approaches.
- 1 June 2005
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1051 (1) , 635-646
Removal of Pathogenic Autoantibodies by Immunoadsorption
Autoimmune diseases result from disrupted tolerance to self-antigens and subsequent damage to tissues and organs. In several diseases, specific autoantibodies have been either proved or suspected to play a role in this process. Consequently, several strategies have been devised in an attempt to discard the destructive immunoglobulins. Currently, both nonselective and epitope-specific methods are applied in several diseases. In this review, we provide a summary of the available data on elimination of pathogenic autoantibodies and discuss the advantages and pitfalls of the different approaches.